image
Fresenius Medical Care AG & Co. KGaA FMS
Healthcare - Medical - Care Facilities - NYSE - DE
Watchlist
$ 23.23
-2.93 %
$ 13.6 B
Market Cap
23.23
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FMS stock under the worst case scenario is HIDDEN Compared to the current market price of 23.2 USD, Fresenius Medical Care AG & Co. KGaA is HIDDEN

FMS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FMS stock under the base case scenario is HIDDEN Compared to the current market price of 23.2 USD, Fresenius Medical Care AG & Co. KGaA is HIDDEN

FMS Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one FMS stock under the best case scenario is HIDDEN Compared to the current market price of 23.2 USD, Fresenius Medical Care AG & Co. KGaA is HIDDEN

FMS Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart FMS

image
1M -2%
6M 12%
1Y 24%
3Y -38%
5Y -38%
All
$26.0$26.0$25.0$25.0$24.0$24.0$23.0$23.0$22.0$22.0$21.0$21.0$20.0$20.0$19.0$19.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
19.3 B REVENUE
-0.61%
Growth Rates
1Year -0.61%
3Years 3.15%
5Years 2.04%
7Years 1.20%
10Years 4.03%
1.39 B OPERATING INCOME
1.68%
Growth Rates
1Year 1.68%
3Years 66.56%
5Years 14.42%
7Years -7.27%
10Years -2.82%
741 M NET INCOME
1.15%
Growth Rates
1Year 1.15%
3Years -15.29%
5Years -12.43%
7Years -10.04%
10Years -3.30%
2.39 B OPERATING CASH FLOW
-9.23%
Growth Rates
1Year -9.23%
3Years -1.40%
5Years -1.45%
7Years 1.22%
10Years 4.54%
-84.9 M INVESTING CASH FLOW
84.39%
Growth Rates
1Year 84.39%
3Years 58.59%
5Years 51.86%
7Years 29.60%
10Years 27.82%
-2.57 B FINANCING CASH FLOW
-38.24%
Growth Rates
1Year -38.24%
3Years -35.87%
5Years -40.66%
7Years -18.17%
10Years -17.18%
5.08 B REVENUE
6.82%
Growth Rates
1Year -0.61%
3Years 3.15%
5Years 2.04%
7Years 1.20%
10Years 4.03%
259 M OPERATING INCOME
-43.85%
Growth Rates
1Year 1.68%
3Years 66.56%
5Years 14.42%
7Years -7.27%
10Years -2.82%
119 M NET INCOME
-55.10%
Growth Rates
1Year 1.15%
3Years -15.29%
5Years -12.43%
7Years -10.04%
10Years -3.30%
832 M OPERATING CASH FLOW
-15.52%
Growth Rates
1Year -9.23%
3Years -1.40%
5Years -1.45%
7Years 1.22%
10Years 4.54%
0 INVESTING CASH FLOW
0.00%
Growth Rates
1Year 84.39%
3Years 58.59%
5Years 51.86%
7Years 29.60%
10Years 27.82%
0 FINANCING CASH FLOW
0.00%
Growth Rates
1Year -38.24%
3Years -35.87%
5Years -40.66%
7Years -18.17%
10Years -17.18%
Balance Sheet Fresenius Medical Care AG & Co. KGaA
image
Current Assets 7.92 B
Cash & Short-Term Investments 1.45 B
Receivables 3.92 B
Other Current Assets 2.56 B
Non-Current Assets 25.6 B
Long-Term Investments 1.42 B
PP&E 7.26 B
Other Non-Current Assets 17 B
4.31 %11.68 %7.61 %4.22 %21.62 %50.55 %Total Assets$33.6b
Current Liabilities 5.66 B
Accounts Payable 984 M
Short-Term Debt 1.22 B
Other Current Liabilities 3.46 B
Non-Current Liabilities 12.1 B
Long-Term Debt 9.76 B
Other Non-Current Liabilities 2.38 B
5.53 %6.84 %19.43 %54.84 %13.36 %Total Liabilities$17.8b
EFFICIENCY
Earnings Waterfall Fresenius Medical Care AG & Co. KGaA
image
Revenue 19.3 B
Cost Of Revenue 14.6 B
Gross Profit 4.76 B
Operating Expenses 3.36 B
Operating Income 1.39 B
Other Expenses 652 M
Net Income 741 M
20b20b18b18b16b16b14b14b12b12b10b10b8b8b6b6b4b4b2b2b0019b(15b)5b(3b)1b(652m)741mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
24.60% GROSS MARGIN
24.60%
Averages
1Year 24.60%
3Years 25.76%
5Years 27.42%
7Years 28.45%
10Years 29.70%
7.20% OPERATING MARGIN
7.20%
Averages
1Year 7.20%
3Years 4.30%
5Years 3.52%
7Years 5.71%
10Years 8.19%
2.78% NET MARGIN
2.78%
Averages
1Year 2.78%
3Years 2.94%
5Years 4.17%
7Years 5.67%
10Years 6.00%
3.69% ROE
3.69%
Averages
1Year 3.69%
3Years 3.90%
5Years 5.62%
7Years 7.50%
10Years 8.50%
1.60% ROA
1.60%
Averages
1Year 1.60%
3Years 1.65%
5Years 2.29%
7Years 3.24%
10Years 3.66%
3.35% ROIC
3.35%
Averages
1Year 3.35%
3Years 2.02%
5Years 1.66%
7Years 3.02%
10Years 4.51%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Fresenius Medical Care AG & Co. KGaA
image
3b3b2b2b2b2b1b1b500m500m0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 741 M
Depreciation & Amortization 1.74 B
Capital Expenditures -699 M
Stock-Based Compensation 0
Change in Working Capital 444 M
Others -214 M
Free Cash Flow 1.69 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Fresenius Medical Care AG & Co. KGaA
image
Wall Street analysts predict an average 1-year price target for FMS of $21.7 , with forecasts ranging from a low of $11.7 to a high of $27 .
FMS Lowest Price Target Wall Street Target
11.7 USD -49.63%
FMS Average Price Target Wall Street Target
21.7 USD -6.69%
FMS Highest Price Target Wall Street Target
27 USD 16.23%
Price
Max Price Target
Min Price Target
Average Price Target
2828262624242222202018181616141412121010May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.634 USD DIVIDEND PER SHARE
Q1
Q2
Q3
Q4
1.200001.200001.000001.000000.800000.800000.600000.600000.400000.400000.200000.200000.000000.000000.4380.440.51370.6320.65510.83380.70930.61810.634150.70731.150.440.510.630.660.830.710.620.630.0020152015201620162017201720182018201920192020202020212021202220222023202320242024
Download SVG
Download PNG
Download CSV
5. COMPETITION
slide 2 of 11
6. Ownership
Insider Ownership Fresenius Medical Care AG & Co. KGaA
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 3 days ago
Reasons to Add Fresenius Medical Stock to Your Portfolio Now FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns. zacks.com - 6 days ago
4 PEG-Based Value Stocks to Buy Amid Tariff War and Market Bloodbath Here are four PEG-driven value stocks that fit our screening criteria. These are QFIN, SUZ, FMS and JD. zacks.com - 6 days ago
4 Stocks Trading Near 52-Week High With More Upside Potential Stocks like TAP, FMS, TGI and THG are seeing price strength and have a high chance of carrying the momentum forward. zacks.com - 6 days ago
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility. zacks.com - 6 days ago
5 Relative Price Strength Stocks to Navigate Today's Market IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength. zacks.com - 1 week ago
Why Fresenius (FMS) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 1 week ago
4 Best Value Stocks With Low PEG to Boost Your Portfolio Returns Here are four PEG-driven value stocks that fit our screening criteria: JD, UHS, FMS, and QFIN. zacks.com - 1 week ago
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally Three discounted MedTech stocks to gain from the market rebound are PAHC, FMS and INMD. zacks.com - 2 weeks ago
5 Low Price-to-Book Stocks to Include in Your Portfolio for Gains The P/B ratio helps to identify low-priced stocks with high growth prospects. JD, CIO, FMS, ITRI and ENS are some such stocks. zacks.com - 2 weeks ago
4 Value Picks That Could Weather Tariff Volatility and Slowing Growth Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. FMS, ENS, GM & ITRI boast a low P/CF ratio. zacks.com - 2 weeks ago
4 Top PEG Stocks Based on GARP Approach to Smart Investing Here are four discounted PEG stocks, JAZZ, FMS, DAN and ITRI, which qualify our screening criteria. zacks.com - 3 weeks ago
8. Profile Summary

Fresenius Medical Care AG & Co. KGaA FMS

image
COUNTRY DE
INDUSTRY Medical - Care Facilities
MARKET CAP $ 13.6 B
Dividend Yield 0.00%
Description Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Contact Else-KrOener Strasse 1, Bad Homburg, 61352 https://www.freseniusmedicalcare.com
IPO Date Sept. 17, 1996
Employees 111513
Officers Dr. Franklin W. Maddux F.A.C.P. Global Chief Medical Officer & Member of Management Board Dr. Gail-Suzanne Brown Senior Vice President of Research & Development Ms. Helen Giza Chair of Management Board & Chief Executive Officer Mr. Roberto Fuste Executive Advisor for Regional Strategy Mr. Jorg Haring Member of the Management Board, Global Head of Legal,Compliance & Human Resources and Labor Director Mr. Martin Fischer Chief Financial Officer & Member of the Management Board Dr. Dominik Heger Executive Vice President and Head of Investor Relations, Strategic Development & Communications Dr. Katarzyna Mazur-Hofsab Ph.D. Chief Executive Officer of Care Enablement & Member of Management Board Mr. Craig Cordola FACHE, M.B.A., M.H.A. Chief Executive Officer of Care Delivery & Member of Management Board Mr. Joachim Weith Senior Vice President of Corporate Communications & Governmental Affairs